Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA-A02 is a serotype within the human leukocyte antigen (HLA)-A group, a major histocompatibility complex (MHC) class I molecule. It presents peptides derived from intracellular proteins to CD8+ cytotoxic T lymphocytes, playing a critical role in immune surveillance against viruses and tumors. HLA-A02 matching is crucial in transplantation to minimize the risk of rejection. Variants within A*02 exhibit population-specific distributions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Leukocyte Antigen A02 (HLA-A02).